ストックスクリーナーアプリを入手
3.25
0.61%
-0.02
アフターアワーズ：
3.25
前日終値:
$3.27
開ける：
$3.27
24時間の取引高:
660.48K
Relative Volume:
1.89
時価総額：
$257.91M
収益：
$351.37M
当期純損益:
$-174.01M
株価収益率:
-1.57
EPS:
-2.07
ネットキャッシュフロー:
$-126.94M
1週間 パフォーマンス:
+1.25%
1か月 パフォーマンス:
+12.07%
6か月 パフォーマンス:
+10.17%
1年 パフォーマンス:
+0.31%
1日の値動き範囲:
$3.20
$3.275
1週間の範囲:
$3.15
$3.335
52週間の値動き範囲:
$2.455
$4.02
Atea Pharmaceuticals Inc Stock (AVIR) Company Profile
AVIR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AVIR
Atea Pharmaceuticals Inc
|
3.25 | 259.50M | 351.37M | -174.01M | -126.94M | -2.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Atea Pharmaceuticals Inc Stock (AVIR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-08-13 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2023-08-10 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2022-01-06 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2021-11-18 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-20 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-10-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-25 | 開始されました | Evercore ISI | Outperform |
| 2020-11-24 | 開始されました | JP Morgan | Overweight |
| 2020-11-24 | 開始されました | Morgan Stanley | Overweight |
| 2020-11-24 | 開始されました | William Blair | Outperform |
すべてを表示
Atea Pharmaceuticals Inc (AVIR) 最新ニュース
Atea Pharmaceuticals (AVIR) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Applying sector rotation models to Atea Pharmaceuticals Inc.Weekly Profit Analysis & Free Expert Approved Momentum Trade Ideas - newser.com
Atea Pharmaceuticals Inc. stock trend outlook and recovery pathJuly 2025 Summary & Real-Time Stock Price Movement Reports - newser.com
Is Atea Pharmaceuticals Inc. still worth holding after the dipQuarterly Trade Summary & High Win Rate Trade Tips - newser.com
Using economic indicators to assess Atea Pharmaceuticals Inc. potentialMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com
What drives Atea Pharmaceuticals Inc stock priceDividend Reinvestment Plans & Free Fastest Return On Investment - earlytimes.in
Key metrics from Atea Pharmaceuticals Inc.’s quarterly dataJuly 2025 Rallies & Verified Entry Point Detection - newser.com
Is Atea Pharmaceuticals Inc. stock cheap at current valuationExit Point & Verified High Yield Trade Plans - newser.com
Is a relief rally coming for Atea Pharmaceuticals Inc. holdersMarket Weekly Review & Step-by-Step Trade Execution Guides - newser.com
Live market analysis of Atea Pharmaceuticals Inc.Stop Loss & Weekly High Return Opportunities - newser.com
Will Atea Pharmaceuticals Inc. stock split attract more investorsIPO Watch & Daily Profit Maximizing Trade Tips - Fundação Cultural do Pará
Will Atea Pharmaceuticals Inc. stock continue dividend increasesWeekly Trading Summary & Reliable Entry Point Alerts - Fundação Cultural do Pará
Atea Pharmaceuticals’ New HCV Study: Potential Game-Changer? - TipRanks
Atea Pharmaceuticals Advances with Key Phase 1 Study on Bemnifosbuvir/Ruzasvir - TipRanks
Atea Pharmaceuticals’ Promising HCV Treatment Study: Key Insights for Investors - TipRanks
Custom strategy builders for tracking Atea Pharmaceuticals Inc.Dollar Strength & Capital Efficiency Focused Ideas - newser.com
Atea Pharmaceuticals Inc (AVIR) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):